Professor Trent Munro

Industry Professor and Director, Biotechnology Innovation, UQ.

Professor Munro has over 25 years’ research and development experience, including as an executive with multinational biopharmaceutical company Amgen.

He has worked across many of the world’s leading innovation centers, spanning Australia, USA, Germany, India and UK. Professor Munro has held several leadership roles in Australia including Senior Vice President of Therapeutics at Microba, leading the therapeutic development strategy, Director of the National Biologics Facility (NBF), Program Director of the CEPI funded Rapid Response Vaccine pipeline, Director of the ARC Centre for Biopharmaceutical Innovation (CBI) and Senior Group Leader at the Australian Institute for Bioengineering and Nanotechnology (AIBN).

In addition, Professor Munro is Chair of Life Sciences Queensland, scientific co-founder of Cassowary Pharma and sits on the Scientific Advisory Board of Macrobiome Therapeutics. He is currently an Industry Professor and Director of Innovation in Biotechnology at The University of Queensland.